BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26700881)

  • 1. Analysis of Immune Response Markers in Jorge Lobo's Disease Lesions Suggests the Occurrence of Mixed T Helper Responses with the Dominance of Regulatory T Cell Activity.
    Azevedo Mde C; Rosa PS; Soares CT; Fachin LR; Baptista IM; Woods WJ; Garlet GP; Trombone AP; Belone Ade F
    PLoS One; 2015; 10(12):e0145814. PubMed ID: 26700881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th17 and regulatory T cells contribute to the in situ immune response in skin lesions of Jorge Lobo's disease.
    Kanashiro-Galo L; Pagliari C; Barboza TC; de Brito AC; Xavier MB; de Oliveira CM; Unger DA; Sotto MN; Quaresma JA; Duarte MI
    Med Mycol; 2016 Jan; 54(1):23-8. PubMed ID: 26333354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased IL-17A/IL-17F expression ratio represents the key mucosal T helper/regulatory cell-related gene signature paralleling disease activity in ulcerative colitis.
    Iboshi Y; Nakamura K; Fukaura K; Iwasa T; Ogino H; Sumida Y; Ihara E; Akiho H; Harada N; Nakamuta M
    J Gastroenterol; 2017 Mar; 52(3):315-326. PubMed ID: 27178567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cytotoxic T cells may contribute to the in situ immune response in Jorge Lobo's Disease human lesions.
    Alexandre AF; Quaresma JA; Barboza TC; de Brito AC; Xavier MB; de Oliveira CM; Unger DA; Kanashiro-Galo L; Sotto MN; Duarte MI; Pagliari C
    Med Mycol; 2017 Feb; 55(2):145-149. PubMed ID: 27562863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jorge Lobo's disease with malignant degeneration to squamous cell carcinoma: case report.
    de Brito AC; Bittencourt MJS; Gonçalves TDS; Cavalcante RH
    An Bras Dermatol; 2022; 97(1):93-95. PubMed ID: 34836741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jorge Lobo's disease: immunohistochemical characterization of dendritic cells in cutaneous lesions.
    Barboza TC; Quaresma JA; de Brito AC; Xavier MB; de Oliveira CM; Unger DA; Duarte MI; Sotto MN; Pagliari C
    Mycopathologia; 2015 Apr; 179(3-4):269-74. PubMed ID: 25487975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutritional status and immune response in murine experimental Jorge Lobo's disease.
    Barbosa AS; Diório SM; Pedrini SC; Silva SM; Sartori BG; Calvi SA; Pereira PC; Vilani-Moreno FR
    Mycoses; 2015 Sep; 58(9):522-30. PubMed ID: 26156007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over-expression of forkhead box P3 and its association with receptor activator of nuclear factor-kappa B ligand, interleukin (IL) -17, IL-10 and transforming growth factor-beta during the progression of chronic periodontitis.
    Dutzan N; Gamonal J; Silva A; Sanz M; Vernal R
    J Clin Periodontol; 2009 May; 36(5):396-403. PubMed ID: 19419438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage immunophenotypes in Jorge Lobo's disease and lepromatous leprosy- A comparative study.
    Sasso BM; Vallarelli A; Rosa PS; Belone A; Velho P; Cintra ML
    Microb Pathog; 2024 May; 190():106610. PubMed ID: 38484920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of microvasculature phenotype and endothelial activation markers in skin lesions of lacaziosis (Lobomycosis).
    Quaresma JA; Brito MV; Sousa JR; Silva LM; Hirai KE; Araujo RS; de Brito AC; Carneiro FR; Fuzii HT; Pagliari C; Sotto MN; Duarte MI
    Microb Pathog; 2015 Jan; 78():29-36. PubMed ID: 25450888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of Langerhans cells in cutaneous lesions of the Jorge Lobo's disease.
    Quaresma JA; Unger D; Pagliari C; Sotto MN; Duarte MI; de Brito AC
    Acta Trop; 2010 Apr; 114(1):59-62. PubMed ID: 20044969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of allergen-specific immunotherapy on functions of helper and regulatory T cells in patients with seasonal allergic rhinitis.
    Kirmaz C; Ozenturk Kirgiz O; Bayrak P; Yilmaz O; Vatansever S; Ozbilgin K; Onur E; Celik O; Sogut A; Ay G; Yuksel H
    Eur Cytokine Netw; 2011 Mar; 22(1):15-23. PubMed ID: 21421451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous analysis of T helper subsets (Th1, Th2, Th9, Th17, Th22, Tfh, Tr1 and Tregs) markers expression in periapical lesions reveals multiple cytokine clusters accountable for lesions activity and inactivity status.
    Araujo-Pires AC; Francisconi CF; Biguetti CC; Cavalla F; Aranha AM; Letra A; Trombone AP; Faveri M; Silva RM; Garlet GP
    J Appl Oral Sci; 2014; 22(4):336-46. PubMed ID: 25141207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of anesthetic methods on preserving anti-tumor T-helper polarization following hepatectomy.
    Zhou D; Gu FM; Gao Q; Li QL; Zhou J; Miao CH
    World J Gastroenterol; 2012 Jun; 18(24):3089-98. PubMed ID: 22791944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jorge Lobo's disease with restricted labial presentation.
    Miranda MF; Unger DA; Brito AC; Carneiro FA
    An Bras Dermatol; 2011; 86(2):373-4. PubMed ID: 21603828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cytokines and T-bet, GATA3, ROR-γt, and FOXP3 transcription factors of T cell subsets in the natural clinical progression of Type 1 Diabetes.
    Ozgur BA; Cinar SA; Coskunpinar E; Yilmaz A; Altunkanat D; Deniz G; Gurol AO; Yilmaz MT
    Immunol Res; 2023 Jun; 71(3):451-462. PubMed ID: 36595206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki disease.
    Jia S; Li C; Wang G; Yang J; Zu Y
    Clin Exp Immunol; 2010 Oct; 162(1):131-7. PubMed ID: 20718783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous analysis of multiple T helper subsets in leprosy reveals distinct patterns of Th1, Th2, Th17 and Tregs markers expression in clinical forms and reactional events.
    Azevedo MCS; Marques H; Binelli LS; Malange MSV; Devides AC; Silva EA; Fachin LRV; Ghidella CC; Soares CT; Garlet GP; Rosa PS; Belone AFF; Trombone APF
    Med Microbiol Immunol; 2017 Dec; 206(6):429-439. PubMed ID: 28875310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Jorge Lobo's disease.
    Carvalho KA; Floriano MC; Enokihara MM; Mascarenhas MR
    An Bras Dermatol; 2015; 90(4):586-8. PubMed ID: 26375233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The imbalanced profile and clinical significance of T helper associated cytokines in bone marrow microenvironment of the patients with acute myeloid leukemia.
    Sun YX; Kong HL; Liu CF; Yu S; Tian T; Ma DX; Ji CY
    Hum Immunol; 2014 Feb; 75(2):113-8. PubMed ID: 24269703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.